Judy Robinson and her husband Gary Robinson speak to the Review-Journal at their home in Las Vegas, Tuesday, June 8, 2021. Judy has mild cognitive impairment and has been in the clinical trial for aducanumab, a drug designed by Biogen to slow the progression of AlzheimerÕs disease that was recently approved by the FDA. (Rachel Aston/Las Vegas Review-Journal) @rookie__rae